
Walmart resumes sourcing from China
Easter items on display, all made in China, at a Walmart in Rosemead, California, on April 11, 2025. - AFP
BEIJING: US retailer Walmart has resumed product sourcing from some Chinese suppliers, marking a shift in its procurement strategy amid rising inventory pressure and looming price hikes for consumers in the United States, according to Chinese suppliers.
Mu Longsheng, director of Pesitro Healthcare Products — a longtime Walmart supplier in Jiangsu province — said the US retailer informed the company on April 28 to prepare for raw material procurement.
The move signals a partial resumption of sourcing activities that has been paused due to increased US tariffs on Chinese goods.
"Two other US brands have also placed orders with us, though the volumes are still small," Mu said. "They are looking to meet immediate daily demand."
Mu said that retailers have agreed to cover additional tariff costs and that prices are being set based on previous orders.
"Many retailers in the United States are anxious about maintaining stock," he said. "Once their early 2025 shipments — arranged to beat tariff hikes — run out, consumers in the US will start feeling the shortage. Price increases are inevitable."
According to CBS News, executives from Walmart and another mega retailer, Target, have recently privately warned the US government that rising tariffs could severely disrupt supply chains and lead to empty shelves.
A report from the US Commerce Department on Wednesday showed US imports surged at a 41.3 per cent annual rate in the first quarter, driven by a 50.9 per cent increase in goods, as businesses rushed to front-load inventory ahead of potential tariff escalations. The Trump administration elevated tariffs in April, which stand at a 145 per cent rate on many Chinese goods and a ten per cent rate on imports from most other countries.
Industry experts say the renewed orders reflect the limited availability of alternative sourcing outside China.
"US retailers are under pressure. It's not easy to find replacements for Chinese manufacturers in the short term," said Jason Yu, general manager of CTR Market Research.
Industry players in the US argue the real cost falls on US consumers and small businesses. The US Chamber of Commerce spoke out against the Trump administration's trade policy on Thursday, saying recently imposed tariffs could cause damage to many small businesses and that the government should take action to avoid a recession.
"We have heard from a historic number of small businesses who have made it clear: they need immediate relief from tariffs," said Suzanne P. Clark, the chamber's president and CEO.
"As each day goes by, small businesses are increasingly endangered by higher costs and interrupted supply chains that will cause irreparable harm," she wrote.
The chamber sent a letter asking the Trump administration to address the impacts of tariffs by granting "automatic exclusions" for any small business importer, establishing a process for companies to apply for an exclusion if the company can demonstrate that tariffs pose a risk to employment for US workers, and providing exclusions for all products that cannot be produced in the United States or are not readily available.
Clark said raising prices on affected products would only hurt families struggling to pay their bills and urged the administration to protect workers from potential job losses by allowing exemptions for companies who may be forced to lay off their employees. - China Daily/ANN

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
2 hours ago
- The Star
US cuts Chinese medicine purchases threefold in April, according to customs data
MOSCOW, June 8 (Bernama-Sputnik/RIA Novosti) -- The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements. - Bernama-Sputnik-RIA Novosti


The Star
5 hours ago
- The Star
Vietnam exports up as US tariff threat lingers
HANOI: Vietnam's exports rose sharply last month, official figures showed Friday (June 6), as the communist country tries to negotiate relief from swingeing tariffs threatened by US President Donald Trump. May exports stood at US$39.6 billion, according to data from the General Statistics Office, up 17 percent on the same period a year ago, while the year-to-date total reached US$180.2 billion, 14 percent higher than in 2024. Vietnam, a major centre for global brands producing shoes and clothes, says it is making progress in talks with Washington to head off Trump's threatened 46 percent levy. The Southeast Asian manufacturing hub has the third-biggest trade surplus with the United States after China and Mexico, putting it in the firing line for Trump's "Liberation Day" global tariff blitz. Vietnam's overall import-export turnover stood at $78.6 billion in May, 15.5 percent higher than the same month last year. Imports were up by 14.1 percent year on year to stand at $39 billion in May. Processed industrial goods dominated exports, while imports were led by production materials. Despite the tariff uncertainty, the United States remained Vietnam's number one export market with $57 billion in the first five months of 2025 -- up from $44 billion over the same period a year ago. Vietnamese and US trade negotiators meeting in Paris this week agreed to step up the pace of their talks. Vietnam has signed several agreements to buy hundreds of millions of dollars' worth of agricultural products and other raw materials from the United States as it seeks to rebalance their trading partnership. Trump's real estate group also broke ground last month on a $1.5-billion luxury golf resort in Vietnam, while his son Eric Trump has been scouting locations for a potential tower project in Ho Chi Minh City, the country's southern business hub. - AFP


New Straits Times
6 hours ago
- New Straits Times
US cuts chinese medicine purchases threefold in April
MOSCOW: The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements.